Search research articles
Contact Us
Filters
Showing results (21-30 of 100) with videos related to
Page
of 10
Sort By:
Journal of Medicinal Chemistry
|
January 31, 2013
Exploring a new frontier in cancer treatment: targeting the ubiquitin and ubiquitin-like activating enzymes
Sara R da Silva, Stacey-Lynn Paiva, Julie L Lukkarila, et al.
Journal of the American Chemical Society
|
January 7, 2014
An excimer-based, turn-on fluorescent sensor for the selective detection of diphosphorylated proteins in aqueous solution and polyacrylamide gels
Dziyana Kraskouskaya, Matthew Bancerz, Harjeet S Soor, et al.
RSC Chemical Biology
|
August 30, 2021
Optical chemosensors for the detection of proximally phosphorylated peptides and proteins
Aaron D Cabral, Tudor B Radu, Elvin D de Araujo, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2022
Evaluation of Small-Molecule HDAC Inhibitors Through In Vitro and In Cellulo Approaches
Nabanita Nawar, Harsimran Kaur Garcha, Abootaleb Sedighi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 5, 2023
Inhibitor Library Screening of SH2 Domains Through Denaturation-Based Assays
Elvin D de Araujo, Anna Orlova, Qirat F Ashraf, et al.
Journal of Medicinal Chemistry
|
January 12, 2017
Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site
Stacey-Lynn Paiva, Sara R da Silva, Elvin D de Araujo, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
November 26, 2009
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein
Steven Fletcher, Joel A Drewry, Vijay M Shahani, et al.
Oncotarget
|
March 5, 2016
Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent
Daniel P Ball, Andrew M Lewis, Declan Williams, et al.
Critical Reviews in Clinical Laboratory Sciences
|
February 27, 2023
Histone deacetylase inhibitors as a potential new treatment for psoriatic disease and other inflammatory conditions
Jehan Mohammad Nazri, Katerina Oikonomopoulou, Elvin D de Araujo, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2022
Fluorescence Polarization-Based Competition Assays to Evaluate Histone Deacetylase 6 Inhibitors
Qirat F Ashraf, Erica J Quilates, Olasunkanmi O Olaoye, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 100) with videos related to
Sort By:
Page
of 10
Journal of Medicinal Chemistry
|
January 31, 2013
Exploring a new frontier in cancer treatment: targeting the ubiquitin and ubiquitin-like activating enzymes
Sara R da Silva, Stacey-Lynn Paiva, Julie L Lukkarila, et al.
Journal of the American Chemical Society
|
January 7, 2014
An excimer-based, turn-on fluorescent sensor for the selective detection of diphosphorylated proteins in aqueous solution and polyacrylamide gels
Dziyana Kraskouskaya, Matthew Bancerz, Harjeet S Soor, et al.
RSC Chemical Biology
|
August 30, 2021
Optical chemosensors for the detection of proximally phosphorylated peptides and proteins
Aaron D Cabral, Tudor B Radu, Elvin D de Araujo, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2022
Evaluation of Small-Molecule HDAC Inhibitors Through In Vitro and In Cellulo Approaches
Nabanita Nawar, Harsimran Kaur Garcha, Abootaleb Sedighi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 5, 2023
Inhibitor Library Screening of SH2 Domains Through Denaturation-Based Assays
Elvin D de Araujo, Anna Orlova, Qirat F Ashraf, et al.
Journal of Medicinal Chemistry
|
January 12, 2017
Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site
Stacey-Lynn Paiva, Sara R da Silva, Elvin D de Araujo, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
November 26, 2009
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein
Steven Fletcher, Joel A Drewry, Vijay M Shahani, et al.
Oncotarget
|
March 5, 2016
Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent
Daniel P Ball, Andrew M Lewis, Declan Williams, et al.
Critical Reviews in Clinical Laboratory Sciences
|
February 27, 2023
Histone deacetylase inhibitors as a potential new treatment for psoriatic disease and other inflammatory conditions
Jehan Mohammad Nazri, Katerina Oikonomopoulou, Elvin D de Araujo, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2022
Fluorescence Polarization-Based Competition Assays to Evaluate Histone Deacetylase 6 Inhibitors
Qirat F Ashraf, Erica J Quilates, Olasunkanmi O Olaoye, et al.
Page
of 10